{"id":"prasterone-dhea","safety":{"commonSideEffects":[{"rate":null,"effect":"Vaginal discharge"},{"rate":null,"effect":"Vaginal irritation"},{"rate":null,"effect":"Perineal discomfort"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Hot flashes"}]},"_chembl":{"chemblId":"CHEMBL3039094","moleculeType":"Small molecule","molecularWeight":"330.47"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Prasterone is an endogenous steroid hormone that serves as a precursor to both estrogen and testosterone. In postmenopausal women, systemic DHEA levels decline significantly, contributing to vaginal atrophy and related symptoms. By supplementing DHEA, the drug enables local and systemic conversion to active sex hormones, improving vaginal tissue health and alleviating symptoms of genitourinary syndrome of menopause (GSM).","oneSentence":"Prasterone (DHEA) is a steroid hormone precursor that acts as a substrate for the synthesis of estrogen and androgen, restoring hormonal balance in postmenopausal women.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:29:46.967Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to severe dyspareunia due to genitourinary syndrome of menopause (GSM) in postmenopausal women"},{"name":"Vaginal atrophy and related menopausal symptoms"}]},"trialDetails":[{"nctId":"NCT05935761","phase":"PHASE2","title":"Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-06-01","conditions":"Chronic Low Back Pain","enrollment":108},{"nctId":"NCT07443605","phase":"NA","title":"Allostatic Load Assessment Using Hair Cortisol and Dehydroepiandrosterone Sulfate Concentration in Patients Affected by Periodontal Disease","status":"COMPLETED","sponsor":"University of Trieste","startDate":"2021-09-01","conditions":"Stress Disorders","enrollment":42},{"nctId":"NCT07179952","phase":"PHASE2","title":"Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )","status":"NOT_YET_RECRUITING","sponsor":"Indiana University","startDate":"2027-01-01","conditions":"Asthma","enrollment":30},{"nctId":"NCT07407647","phase":"PHASE2","title":"Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer","status":"RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2026-03-01","conditions":"Anal Carcinoma, Cervical Carcinoma, Malignant Female Reproductive System Neoplasm","enrollment":25},{"nctId":"NCT04488757","phase":"NA","title":"Neurobiological Mechanisms of Stress in Youth With Chronic Widespread Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2021-11-04","conditions":"Chronic Widespread Pain, Stress, Psychological, Stress, Physiological","enrollment":70},{"nctId":"NCT07353515","phase":"","title":"Peri-Implant Sulcus Fluid Stress Markers in Health and Disease","status":"COMPLETED","sponsor":"Inonu University","startDate":"2023-02-15","conditions":"Peri-implantitis, Peri-implant Mucositis, Peri-Implant Health","enrollment":62},{"nctId":"NCT07323329","phase":"PHASE2, PHASE3","title":"Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization","status":"RECRUITING","sponsor":"Beni-Suef University","startDate":"2025-10-10","conditions":"Infertility, Infertility (IVF Patients)","enrollment":165},{"nctId":"NCT03648385","phase":"PHASE2","title":"Effects of DHEA in Pulmonary Hypertension","status":"COMPLETED","sponsor":"Rhode Island Hospital","startDate":"2019-01-09","conditions":"Pulmonary Arterial Hypertension","enrollment":26},{"nctId":"NCT03228732","phase":"EARLY_PHASE1","title":"The Effects of Fluoxetine and/or DHEA","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2017-12-19","conditions":"Type 1 Diabetes Mellitus","enrollment":60},{"nctId":"NCT07158125","phase":"","title":"Pathogenesis of Periodontal Disease in Individuals With Psoriasis","status":"NOT_YET_RECRUITING","sponsor":"Recep Tayyip Erdogan University Training and Research Hospital","startDate":"2025-09-15","conditions":"Psoriasis","enrollment":60},{"nctId":"NCT07116317","phase":"","title":"Salivary Stress Markers Associated With Malocclusion Severity","status":"NOT_YET_RECRUITING","sponsor":"Recep Tayyip Erdogan University Training and Research Hospital","startDate":"2025-08-11","conditions":"Malocclusion","enrollment":120},{"nctId":"NCT05293366","phase":"","title":"LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions","status":"RECRUITING","sponsor":"Federico II University","startDate":"2022-01-27","conditions":"Long Covid-19","enrollment":100},{"nctId":"NCT05562518","phase":"PHASE4","title":"GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2022-03-21","conditions":"Vulvovaginal Atrophy, Breast Cancer","enrollment":160},{"nctId":"NCT05623059","phase":"PHASE1, PHASE2","title":"Evaluate Pharmacokinetics and Safety of Slow Release DHEA","status":"COMPLETED","sponsor":"Indiana University","startDate":"2023-03-03","conditions":"Asthma, Genotype","enrollment":18},{"nctId":"NCT06472765","phase":"","title":"Vaginal Ecosystem and Network in the United States Study","status":"ENROLLING_BY_INVITATION","sponsor":"Vaginal Biome Science","startDate":"2024-05-16","conditions":"Bacterial Vaginosis, Candidiasis, Urinary Tract Infections","enrollment":3250},{"nctId":"NCT06852560","phase":"NA","title":"A Trial Assessing Feasibility of Allostatic Load Biomarkers and CVD Risk Among Black Breast Cancer Survivors","status":"WITHDRAWN","sponsor":"University of Florida","startDate":"2025-05","conditions":"Breast Cancer","enrollment":""},{"nctId":"NCT02357472","phase":"NA","title":"The Effect of a Higher Dose of Dehydroepiandrosterone (DHEA) Supplementation in Poor Responders","status":"TERMINATED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2014-01-01","conditions":"Infertility","enrollment":60},{"nctId":"NCT05692960","phase":"NA","title":"Women's Interventions for Sexual Health: WISH","status":"COMPLETED","sponsor":"The University of Tennessee, Knoxville","startDate":"2023-02-15","conditions":"Sexual Dysfunction, Physiological, Body Image, Libido; Loss, Aversion","enrollment":30},{"nctId":"NCT04979377","phase":"","title":"Prevalence of Hyperandrogenism in Type 1 Diabetes","status":"COMPLETED","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","startDate":"2020-03-09","conditions":"Type 1 Diabetes, Polycystic Ovary Syndrome, Hyperandrogenism","enrollment":150},{"nctId":"NCT05586711","phase":"PHASE4","title":"Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women","status":"COMPLETED","sponsor":"Angelica Lindén Hirschberg","startDate":"2020-12-18","conditions":"Vulvovaginal Atrophy, Genitourinary Syndrome of Menopause","enrollment":170},{"nctId":"NCT06729359","phase":"","title":"Polycystic Ovary Syndrome and Urinary Tract Stones: a BMI-Adjusted Analysis in Iraqi Women","status":"COMPLETED","sponsor":"Al-Kindy College of Medicine","startDate":"2024-07-01","conditions":"PCOS (Polycystic Ovary Syndrome), Stone, Urinary, BMI","enrollment":407},{"nctId":"NCT05316272","phase":"NA","title":"Effects of DHEA and Exercise on Bone Marrow Fat in Postmenopausal Women","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2022-03-11","conditions":"Low Bone Density, Osteoporosis","enrollment":41},{"nctId":"NCT03227458","phase":"NA","title":"DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2018-02-12","conditions":"Low Bone Mass, Osteoporosis, Postmenopausal","enrollment":152},{"nctId":"NCT04493333","phase":"PHASE2","title":"Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors","status":"TERMINATED","sponsor":"University of Arkansas","startDate":"2021-06-07","conditions":"Vaginal Atrophy, Postmenopausal Symptoms, Breast Cancer Female","enrollment":8},{"nctId":"NCT06611514","phase":"PHASE3","title":"Effect of Intravaginal Prasterone on Symptoms of Genitourinary Syndrome of Menopause (GSM) in Women in Menopause With Previous Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"European Institute of Oncology","startDate":"2024-12-01","conditions":"Women With Breast Cancer","enrollment":95},{"nctId":"NCT04982692","phase":"PHASE3","title":"A Clinical Study of INTRAROSA® (Prasterone) Vaginal Inserts in Postmenopausal Vulvovaginal Atrophy","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2021-09-13","conditions":"Postmenopausal Vulvovaginal Atrophy","enrollment":417},{"nctId":"NCT05471453","phase":"NA","title":"Effectiveness of Adjuvant Supplements Prior to in IVF","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2022-03-02","conditions":"Dietary Supplements","enrollment":70},{"nctId":"NCT03383133","phase":"EARLY_PHASE1","title":"Studies of Sulfur Metabolism in Humans","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2018-01-11","conditions":"Metabolic Side Effects of Drugs","enrollment":1},{"nctId":"NCT05434351","phase":"","title":"The Outcome of Chinese Women With Genitourinary Syndrome of Menopause Treated With Vaginal Dehydroepiandrosterone","status":"TERMINATED","sponsor":"Chinese University of Hong Kong","startDate":"2022-08-01","conditions":"Genitourinary Syndrome of Menopause","enrollment":4},{"nctId":"NCT05263557","phase":"NA","title":"Dissecting the IMpact of 11-OXygenated and Classic Androgens on Skeletal Muscle Insulin Sensitivity (DIMOXIS)","status":"UNKNOWN","sponsor":"Royal College of Surgeons, Ireland","startDate":"2022-08-19","conditions":"Polycystic Ovary Syndrome, Insulin Resistance, Androgen; Hypersecretion","enrollment":20},{"nctId":"NCT02432248","phase":"NA","title":"Effect of DHEA on Patients With Poor Ovarian Responds","status":"UNKNOWN","sponsor":"The Affiliated Hospital of Inner Mongolia Medical University","startDate":"2015-02","conditions":"Subfertility","enrollment":350},{"nctId":"NCT05900661","phase":"PHASE2, PHASE3","title":"The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-07-30","conditions":"Poor Responders","enrollment":300},{"nctId":"NCT05346159","phase":"","title":"Effects of Adrenal Androgens on Gender-typed Behavior in Girls With Turner Syndrome","status":"COMPLETED","sponsor":"Sohag University","startDate":"2022-05-01","conditions":"Turner Syndrome","enrollment":78},{"nctId":"NCT03491007","phase":"PHASE2","title":"Neurosteroids in PTSD - Biomarkers to Therapeutics","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2019-07-08","conditions":"Posttraumatic Stress Disorder","enrollment":5},{"nctId":"NCT05811507","phase":"","title":"Evaluation of Serum Adrenal Androgens Among Prepubertal and Pubertal Boys With Autism Spectrum Disorder","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2023-04","conditions":"Autism Spectrum Disorder","enrollment":100},{"nctId":"NCT05246865","phase":"NA","title":"Impact of 11-oxygenated Androgens on Metabolic Dysfunction of Women With Polycystic Ovary Syndrome","status":"UNKNOWN","sponsor":"University of Birmingham","startDate":"2021-10-10","conditions":"Polycystic Ovary Syndrome","enrollment":100},{"nctId":"NCT04066478","phase":"PHASE2, PHASE3","title":"Does DHEA IVF Outcomes in Poor Responders?","status":"SUSPENDED","sponsor":"Homerton University Hospital NHS Foundation Trust","startDate":"2017-10-08","conditions":"Infertility, Female, Poor Response to Ovulation Induction","enrollment":400},{"nctId":"NCT03568604","phase":"PHASE4","title":"Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia","status":"COMPLETED","sponsor":"San Diego Sexual Medicine","startDate":"2018-08-07","conditions":"Dyspareunia","enrollment":18},{"nctId":"NCT04833192","phase":"","title":"Evaluation of New Diagnostic Indicator of Subclinical Hypercortisolism","status":"UNKNOWN","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2020-04-01","conditions":"Adrenal Incidentaloma, Subclinical Hypercortisolism","enrollment":202},{"nctId":"NCT04705883","phase":"PHASE4","title":"Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2020-09-01","conditions":"Vulvar Atrophy, Breast Cancer, Genitourinary Syndrome of Menopause","enrollment":10},{"nctId":"NCT04517136","phase":"","title":"Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions","status":"UNKNOWN","sponsor":"Direction Centrale du Service de Santé des Armées","startDate":"2020-09-14","conditions":"Covid19, SARS-CoV Infection, Burnout, Caregiver","enrollment":39},{"nctId":"NCT01273259","phase":"PHASE2","title":"Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2008-05-06","conditions":"Chronic Obstructive Pulmonary Disease, Hypertension, Pulmonary","enrollment":51},{"nctId":"NCT05033574","phase":"","title":"The State of Sexual Development in Children With Inherited Epidermolysis Bullosa","status":"UNKNOWN","sponsor":"National Medical Research Center for Children's Health, Russian Federation","startDate":"2020-12-08","conditions":"Dermatologic Disease, Epidermolysis Bullosa, Epidermolysis Bullosa Simplex","enrollment":50},{"nctId":"NCT03854396","phase":"PHASE3","title":"Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women","status":"WITHDRAWN","sponsor":"Olivia Cardenas-Trowers, M.D.","startDate":"2020-05","conditions":"Recurrent Urinary Tract Infection, Postmenopause, Postmenopausal Syndrome","enrollment":""},{"nctId":"NCT04898556","phase":"PHASE3","title":"Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular Pain","status":"UNKNOWN","sponsor":"Dr. Santiago Palacios","startDate":"2020-12-22","conditions":"Vulvovaginal Atrophy","enrollment":50},{"nctId":"NCT03287232","phase":"PHASE3","title":"Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2017-10-16","conditions":"Hypoactive Sexual Desire Disorder","enrollment":653},{"nctId":"NCT03438812","phase":"NA","title":"Dehydroepiandrosterone Maintain Mitochondrial Quality of Cumulus Cells in Poor Ovarian Responders","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2017-09-06","conditions":"Poor Responders, Dehydroepiandrosterone","enrollment":66},{"nctId":"NCT01662466","phase":"PHASE1, PHASE2","title":"Effect of Testosterone Treatment on Embryo Quality","status":"UNKNOWN","sponsor":"Center for Human Reproduction","startDate":"2012-07-01","conditions":"Primary Ovarian Insufficiency, Female Infertility Due to Diminished Ovarian Reserve","enrollment":180},{"nctId":"NCT04555018","phase":"","title":"Correlation Between Dehydroepiandrosterone Sulfate and Sebum Level in Adult Female Acne Vulgaris","status":"COMPLETED","sponsor":"Dr.dr.Irma Bernadette, SpKK (K)","startDate":"2017-06-01","conditions":"Acne Vulgaris, Female","enrollment":50},{"nctId":"NCT03740945","phase":"PHASE3","title":"Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer","status":"WITHDRAWN","sponsor":"EndoCeutics Inc.","startDate":"2018-11-06","conditions":"Vaginal Atrophy in Breast Cancer Patients","enrollment":""},{"nctId":"NCT03619005","phase":"PHASE3","title":"Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study","status":"WITHDRAWN","sponsor":"EndoCeutics Inc.","startDate":"2018-11-13","conditions":"Hypoactive Sexual Desire Disorder (HSDD)","enrollment":""},{"nctId":"NCT04355663","phase":"NA","title":"Neuroproprioceptive \"Facilitation, Inhibition\" and Brain Plasticity","status":"COMPLETED","sponsor":"Charles University, Czech Republic","startDate":"2015-05-20","conditions":"Multiple Sclerosis","enrollment":92},{"nctId":"NCT04379193","phase":"NA","title":"Physical Therapy and Neuroactive Steroids Therapy Does Not Modulate Serum Level of Neuroactive Steroids","status":"COMPLETED","sponsor":"Charles University, Czech Republic","startDate":"2015-05-20","conditions":"Multiple Sclerosis","enrollment":63},{"nctId":"NCT04369248","phase":"","title":"Hepassocin Levels in Patients With Polycystic Ovary Syndrome","status":"COMPLETED","sponsor":"Fatma ketenci gencer","startDate":"2020-01-03","conditions":"Hepassocin (Hepatocyte-derived Fibrinogen-related Protein 1), Polycystic Ovary Syndrome, Obesity","enrollment":90},{"nctId":"NCT03418363","phase":"PHASE4","title":"How DHEA Supplements Affect Coagulation in Women Using Birth Control Pills","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2018-01-16","conditions":"Contraceptive Usage, Coagulation","enrollment":15},{"nctId":"NCT02866253","phase":"PHASE4","title":"Dehydroepiandrosterone (DHEA)Supplementation Pre-IVF(In Vitro Fertilization) Cycles","status":"COMPLETED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2014-12","conditions":"Infertility","enrollment":78},{"nctId":"NCT00972023","phase":"PHASE1","title":"DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer","status":"TERMINATED","sponsor":"Barbara Ann Karmanos Cancer Institute","startDate":"2010-02","conditions":"Breast Cancer","enrollment":1},{"nctId":"NCT00607646","phase":"EARLY_PHASE1","title":"Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2010-10","conditions":"Type 1 Diabetes","enrollment":50},{"nctId":"NCT02683148","phase":"PHASE1","title":"DHEA in Synovial Sarcoma Patients","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2016-09-13","conditions":"Synovial Sarcoma, Sarcoma, Synovial","enrollment":11},{"nctId":"NCT03967964","phase":"PHASE1","title":"Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA)","status":"COMPLETED","sponsor":"Laboratorios Andromaco S.A.","startDate":"2015-11-20","conditions":"Pharmacokinetics, Hormone Deficiency","enrollment":46},{"nctId":"NCT02268032","phase":"PHASE1","title":"Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian Reserve","status":"COMPLETED","sponsor":"Laboratorios Andromaco S.A.","startDate":"2014-07-15","conditions":"Healthy Women, Infertility, Female","enrollment":94},{"nctId":"NCT01376349","phase":"PHASE3","title":"Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2011-07","conditions":"Breast Cancer, Gynecologic Cancer","enrollment":464},{"nctId":"NCT03782480","phase":"PHASE3","title":"Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy","status":"UNKNOWN","sponsor":"Center for Vulvovaginal Disorders","startDate":"2019-03-02","conditions":"Menopause, Genitourinary Syndrome of Menopause, Vulvovaginal Atrophy","enrollment":40},{"nctId":"NCT03783988","phase":"PHASE1","title":"Study With a Topical Gel Containing TRIAC and DHEA in Subjects With Skin Atrophy Due to Glucocorticoids","status":"UNKNOWN","sponsor":"Trophea Development AB","startDate":"2019-01-15","conditions":"Skin Atrophy","enrollment":10},{"nctId":"NCT01535872","phase":"PHASE3","title":"Study of Dehydroepiandrosterone Treatment for Poor Responders in In Vitro Fertilization Patients","status":"COMPLETED","sponsor":"KK Women's and Children's Hospital","startDate":"2012-02","conditions":"Infertility, Poor Responder to IVF Treatment","enrollment":60},{"nctId":"NCT00310791","phase":"PHASE2, PHASE3","title":"Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2004-04","conditions":"Anorexia Nervosa","enrollment":80},{"nctId":"NCT02794948","phase":"PHASE1, PHASE2","title":"Chinese Medicine(Hu Yang Yang Kun Formula) for Primary Ovarian Insufficiency","status":"COMPLETED","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2016-04","conditions":"Primary Ovarian Insufficiency","enrollment":48},{"nctId":"NCT02766764","phase":"PHASE4","title":"Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2016-06","conditions":"Subfertility","enrollment":230},{"nctId":"NCT01256671","phase":"PHASE3","title":"DHEA Against Vaginal Atrophy - Safety Study of 12 Months","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2010-12","conditions":"Vaginal Atrophy","enrollment":530},{"nctId":"NCT01846442","phase":"PHASE3","title":"Topical DHEA Against Vaginal Atrophy","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2007-06","conditions":"Vaginal Atrophy","enrollment":218},{"nctId":"NCT01256684","phase":"PHASE3","title":"DHEA Against Vaginal Atrophy - 3-Month Efficacy Study","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2010-12","conditions":"Vaginal Atrophy","enrollment":255},{"nctId":"NCT01358760","phase":"PHASE3","title":"Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2011-06","conditions":"Vaginal Atrophy","enrollment":450},{"nctId":"NCT02013544","phase":"PHASE3","title":"Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2014-02","conditions":"Vaginal Atrophy","enrollment":558},{"nctId":"NCT02549690","phase":"NA","title":"Testosterone Gel in Poor Responders Undergoing IVF","status":"WITHDRAWN","sponsor":"Vietnam National University","startDate":"2015-09","conditions":"Infertility","enrollment":""},{"nctId":"NCT00429806","phase":"PHASE1","title":"DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy","status":"COMPLETED","sponsor":"CHU de Quebec-Universite Laval","startDate":"2006-11","conditions":"Vaginal Atrophy","enrollment":40},{"nctId":"NCT00248989","phase":"PHASE3","title":"Effect of DHEA on Skin Aging in Postmenopausal Women","status":"COMPLETED","sponsor":"CHU de Quebec-Universite Laval","startDate":"2004-11-01","conditions":"Skin Aging, Quality of Life","enrollment":150},{"nctId":"NCT00317148","phase":"PHASE2, PHASE3","title":"Effect of Dehydroepiandrosterone (DHEA) on Hot Flashes in Postmenopausal Women","status":"COMPLETED","sponsor":"CHU de Quebec-Universite Laval","startDate":"2005-08","conditions":"Hot Flashes","enrollment":50},{"nctId":"NCT02229604","phase":"PHASE1","title":"Electroacupuncture for Diminished Ovarian Reserve","status":"COMPLETED","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2014-01","conditions":"Irregular Menses","enrollment":57},{"nctId":"NCT02000375","phase":"PHASE2","title":"A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)","status":"TERMINATED","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2013-03","conditions":"Metastatic Breastcancer, Estrogen Receptor Positive Breast Cancer, Estrogen Receptor Negative Neoplasm","enrollment":20},{"nctId":"NCT00516698","phase":"","title":"Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2007-09","conditions":"Breast Cancer","enrollment":140},{"nctId":"NCT02561793","phase":"PHASE3","title":"DHEA Versus Placebo in Women With Poor Ovarian Response","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2015-10","conditions":"Subfertility","enrollment":440},{"nctId":"NCT02736591","phase":"PHASE3","title":"Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2016-06","conditions":"Subfertility","enrollment":210},{"nctId":"NCT00189124","phase":"PHASE2, PHASE3","title":"Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2003-09","conditions":"Systemic Lupus Erythematosus","enrollment":13},{"nctId":"NCT00005246","phase":"","title":"Epidemiology of Insulin and Dehydroepiandrosterone Sulfate and Coronary Heart Disease Mortality","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1989-08","conditions":"Cardiovascular Diseases, Heart Diseases, Coronary Disease","enrollment":""},{"nctId":"NCT00289926","phase":"PHASE3","title":"Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms","status":"COMPLETED","sponsor":"Monash University","startDate":"2006-02","conditions":"Quality of Life, Menopausal Syndrome, Libido Disorder","enrollment":240},{"nctId":"NCT00202163","phase":"PHASE2","title":"ANDRO 2002: Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction","status":"COMPLETED","sponsor":"Queen's University","startDate":"2006-12","conditions":"Erectile Dysfunction","enrollment":120},{"nctId":"NCT01572025","phase":"PHASE3","title":"Dehydroepiandrosterone (DHEA) Intervention To Treat Ovarian Aging","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2012-05","conditions":"Infertility, Ovarian Aging, Diminished Ovarian Reserve (DOR)","enrollment":60},{"nctId":"NCT01861847","phase":"PHASE2","title":"7-Keto DHEA for the Treatment of PTSD","status":"COMPLETED","sponsor":"Humanetics Corporation","startDate":"2013-02","conditions":"PTSD","enrollment":71},{"nctId":"NCT00650754","phase":"PHASE2, PHASE3","title":"Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility","status":"TERMINATED","sponsor":"Center for Human Reproduction","startDate":"2008-03","conditions":"Primary Ovarian Insufficiency, Unexplained Infertility","enrollment":35},{"nctId":"NCT02151006","phase":"PHASE3","title":"Does Dehydro Epiandrosterone (DHEA) Improve Pregnancy Rate in Women Undergoing IVF/ICSI With Expected Poor Ovarian Response?","status":"COMPLETED","sponsor":"Cairo University","startDate":"2014-05","conditions":"Subfertility","enrollment":140},{"nctId":"NCT00581087","phase":"PHASE3","title":"Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults","status":"UNKNOWN","sponsor":"University Hospital, Bordeaux","startDate":"2007-01","conditions":"Chronic Obstructive Pulmonary Disease, Hypertension, Pulmonary","enrollment":60},{"nctId":"NCT00566384","phase":"PHASE2","title":"Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-11","conditions":"Libido","enrollment":100},{"nctId":"NCT01129830","phase":"EARLY_PHASE1","title":"The Effect of DHEA on Markers of Ovarian Reserve in Women With Diminished Ovarian Reserve","status":"TERMINATED","sponsor":"Virginia Center for Reproductive Medicine","startDate":"2010-01","conditions":"Infertility","enrollment":200},{"nctId":"NCT02099916","phase":"PHASE2, PHASE3","title":"Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVF","status":"UNKNOWN","sponsor":"University of Athens","startDate":"2014-10","conditions":"Efficacy of DHEA, Pregnancy Rate, Diminished Ovarian Reserve","enrollment":50},{"nctId":"NCT02150330","phase":"PHASE3","title":"Effects of Dehydroepiandrosterone Supplementation on Cumulus Cells Gene Expression Under Controlled Ovarian Hyper-stimulation in Patients With Diminished Ovarian Reserve","status":"COMPLETED","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2013-01","conditions":"Dehydroepiandrosterone, DHEAS, Gene Expression of Cumulus Cells.","enrollment":40},{"nctId":"NCT02132559","phase":"","title":"Effect of Dehydroepiandrosterone Administration in Patients With Poor Ovarian Response According to the Bologna Criteria","status":"COMPLETED","sponsor":"Chinese Medical Association","startDate":"2011-10","conditions":"Infertility","enrollment":386},{"nctId":"NCT01915186","phase":"NA","title":"Use of Dehydroepiandrosterone (DHEA) in Women With Normal and Poor Ovarian Reserve Undergoing IVF","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2010-10","conditions":"Female Infertility Due to Diminished Ovarian Reserve","enrollment":104},{"nctId":"NCT01452373","phase":"PHASE3","title":"Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2011-10","conditions":"Vasomotor Symptoms, Hot Flushes","enrollment":238},{"nctId":"NCT01753037","phase":"NA","title":"Effects of Androgen Administration on Inflammation in Normal Women","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2006-12","conditions":"Hyperandrogenism","enrollment":25},{"nctId":"NCT01129947","phase":"EARLY_PHASE1","title":"The Use of DHEA in Women With Premature Ovarian Failure","status":"WITHDRAWN","sponsor":"Virginia Center for Reproductive Medicine","startDate":"2010-05","conditions":"Premature Ovarian Failure","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Intrarosa"],"phase":"phase_3","status":"active","brandName":"Prasterone (DHEA)","genericName":"Prasterone (DHEA)","companyName":"EndoCeutics Inc.","companyId":"endoceutics-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Prasterone (DHEA) is a steroid hormone precursor that acts as a substrate for the synthesis of estrogen and androgen, restoring hormonal balance in postmenopausal women. Used for Moderate to severe dyspareunia due to genitourinary syndrome of menopause (GSM) in postmenopausal women, Vaginal atrophy and related menopausal symptoms.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}